Baker Bros. Advisors LP 13D/13G Filings for Talis Biomedical Corporation (TLIS)

Baker Bros. Advisors LP 13D and 13G filings for Talis Biomedical Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-10
5:01 pm
Purchase
2024-10-08 13D Talis Biomedical Corporation
TLIS
Baker Bros. Advisors LP 2,507,193
65.600%
2,507,193increase
(New Position)
Filing